{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:37:15Z","timestamp":1762508235238,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.anndiagpath.2020.151624","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:32:45Z","timestamp":1599211965000},"page":"151624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma"],"prefix":"10.1016","volume":"49","author":[{"given":"Meriam","family":"Triki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihene","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Mellouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slim","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahya","family":"Boudawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151624_bb0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA-Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0015","first-page":"90","article-title":"Colloid carcinoma","volume":"77","author":"Parham","year":"1923","journal-title":"Ann Surg"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00384-013-1826-2","article-title":"Overall survival is improved in mucinous adenocarcinoma of the colon","volume":"29","author":"Hogan","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0025","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ijo_00000238","article-title":"Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada","volume":"34","author":"Xie","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0030","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/modpathol.3800093","article-title":"Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival","volume":"17","author":"Kakar","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0035","first-page":"967","article-title":"Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer","volume":"25","author":"Buecher","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0955-0674(95)80102-2","article-title":"Morphogenetic roles of classic cadherins","volume":"7","author":"Takeichi","year":"1995","journal-title":"Curr Opin Cell Biol"},{"year":"2017","series-title":"UICC (Union for International Cancer Control) TNM classification of malignant Tumours","author":"Brierley","key":"10.1016\/j.anndiagpath.2020.151624_bb0045"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0050","article-title":"Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acthis.2011.11.002","article-title":"Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma","volume":"114","author":"Miladi-Abdennadher","year":"2012","journal-title":"Acta Histochem"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000107105","article-title":"Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy","volume":"71","author":"Giralt","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1572-0241.2002.05625.x","article-title":"Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer","volume":"97","author":"Zhang","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/IJGC:31:1-3:147","article-title":"Expression of cyclooxygenase-2 protein in colorectal carcinomas","volume":"31","author":"Joo","year":"2002","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1245\/s10434-007-9757-1","article-title":"Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features","volume":"15","author":"Leopoldo","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/modpathol.3800482","article-title":"Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component","volume":"19","author":"Ogino","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0085","first-page":"71","article-title":"Histopathological and immunohistochemical study of the prognostic significance of Cox2 and CDX2 expression in the available cases of colorectal carcinoma","volume":"87","author":"Asmaa","year":"2019","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0090","first-page":"228","article-title":"Correlation of COX-2 expression in colorectal carcinoma with clinicopathological features","volume":"33","author":"Venkatachala","year":"2017","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4236\/ojpathology.2018.83013","article-title":"Prognostic value of combined; cox-2, cyclin D1 and P21 expression in colorectal cancer (CRC) patients: an Immunohistochemical study","volume":"8","author":"Salem","year":"2018","journal-title":"Open J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0100","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1158\/1078-0432.CCR-04-0653","article-title":"Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer","volume":"10","author":"Soumaoro","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1025863029529","article-title":"Role of cyclooxygenase-2 in colorectal cancer","volume":"23","author":"Sinicrope","year":"2004","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.kjms.2017.03.004","article-title":"Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: a population-based cohort study","volume":"33","author":"Huang","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0115","first-page":"5473","article-title":"Reduced COX-2 protein in colorectal cancer with defective mismatch repair","volume":"58","author":"Karnes","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0120","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10620-012-2552-2","article-title":"Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer","volume":"58","author":"Jie","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.20317","article-title":"Neoexpression of N-cadherin in E-cadherin positive colon cancers","volume":"111","author":"Rosivatz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ijc.10690","article-title":"Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region","volume":"102","author":"Kanazawa","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.anndiagpath.2013.05.007","article-title":"Differential caveolin-1 expression in colon carcinoma and its relation to E-cadherin\u2013\u03b2-catenin complex","volume":"17","author":"Alshenawy","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0140","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1007\/s13277-015-3115-x","article-title":"Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma","volume":"36","author":"Foda","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0145","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12253-011-9409-4","article-title":"Prognostic significance of Wnt-1, \u03b2-catenin and E-cadherin expression in advanced colorectal carcinoma","volume":"17","author":"Stanczak","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/bjc.2015.347","article-title":"Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis","volume":"114","author":"Kim","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0155","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T","article-title":"American joint committee on cancer prognostic factors consensus conference: colorectal working group","volume":"88","author":"Compton","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151624_bb0160","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1158\/0008-5472.CAN-06-1818","article-title":"RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility","volume":"66","author":"Chang","year":"2006","journal-title":"Cancer Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:24Z","timestamp":1761078744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S1092913420301702"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151624","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151624"}}